Alpha Teknova (NASDAQ:TKNO) Releases Quarterly Earnings Results

Alpha Teknova (NASDAQ:TKNO) released its earnings results on Tuesday. The company reported ($0.11) earnings per share (EPS) for the quarter, Zacks reports. The company had revenue of $9.27 million during the quarter, compared to analysts’ expectations of $9.10 million. Alpha Teknova had a negative net margin of 87.17% and a negative return on equity of 35.30%. Alpha Teknova updated its FY 2025 guidance to EPS.

Alpha Teknova Trading Down 1.2 %

NASDAQ:TKNO opened at $5.97 on Thursday. Alpha Teknova has a 1 year low of $1.16 and a 1 year high of $10.37. The stock has a market cap of $318.25 million, a P/E ratio of -8.07 and a beta of 0.34. The company has a debt-to-equity ratio of 0.12, a quick ratio of 3.94 and a current ratio of 4.73. The stock has a 50-day simple moving average of $8.22 and a 200-day simple moving average of $6.88.

Wall Street Analyst Weigh In

Separately, Craig Hallum initiated coverage on shares of Alpha Teknova in a report on Monday, February 10th. They issued a “buy” rating and a $12.00 target price on the stock.

Alpha Teknova Company Profile

Alpha Teknova, Inc produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.